Dr. Alexandra T. Greenhill, new Cancer Research Society Director
December 8, 2023 — Christian Paupe, Chairman of the Board of Directors of the Cancer Research Society (CRS), is delighted to announce the appointment of Dr. Alexandra T. Greenhill as a director. A distinguished physician, Dr. Greenhill is also founder, CEO and Chief Medical Officer of Careteam Technologies, a novel digital platform dedicated to supporting complex health, and an innovation entrepreneur within the healthcare system.
Over the years, she has held leadership positions in both the healthcare system and at a variety of companies. She is also a dedicated campaigner for the advancement of the role of women in science, technology, engineering and mathematics (STEM) and the co-creator of Littlecodr, a game to teach kids coding.
Highly involved in the community, she speaks on, and moderates, panels discussing leadership, technology, start-ups, healthcare, business and education. Dr. Greenhill is currently Chair of the Board of Vancouver Foundation and of Physician Innovator, and serves on the Board of Canadian Institute for Health Information (CIHI). She is the co-editor and author of “AI in Clinical Medicine” (Wiley, 2023).
“I can’t think of anyone who isn’t affected by cancer. Of course, for me there are my patients, but also family, friends and colleagues. In my decades of practice, I have seen first hand how science made some cancers preventable and curable. I am passionate about joining the CRS Board of Directors, which helps fund such cancer research projects across the country.”
– Dr. Alexandra T. Greenhill
About our Board of Directors:
Comprised of community leaders, senior executives and experienced professionals, our board directors are high-level executives who guide the CRS’s strategic initiatives. They are key players within our organization in working to outsmart cancer through research.